All Stories

  1. Pharmacokinetics ofpara-Aminosalicylic Acid in HIV-Uninfected and HIV-Coinfected Tuberculosis Patients Receiving Antiretroviral Therapy, Managed for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Professor Bernd Rosenkranz

  2. Biomarkers of HIV-associated Cancer

    Article • Biomarkers in Cancer, July 2014, Libertas Academica, Ltd.

    Professor Bernd Rosenkranz

  3. Drug–drug interactions in HIV positive cancer patients

    Article • Biomedicine & Pharmacotherapy, June 2014, Elsevier

    Professor Bernd Rosenkranz

  4. Inhibition of Major Drug Metabolizing CYPs by Common Herbal Medicines used by HIV/AIDS Patients in Africa– Implications for Herb- Drug Interactions

    Article • Drug Metabolism Letters, May 2014, Bentham Science Publishers

    Professor Bernd Rosenkranz

  5. Editorial (Thematic Issue: Diagnosis and Management of Malaria: An Updated Report on a Deadly Disease of Global Impact)

    Article • Infectious Disorders - Drug Targets, January 2014, Bentham Science Publishers

    Professor Bernd Rosenkranz

  6. Are lopinavir and efavirenz serum concentrations in HIV-infected children in the therapeutic range in clinical practice?

    Article • Paediatrics and International Child Health, December 2013, Taylor & Francis

    Professor Bernd Rosenkranz

  7. The potential ofHypoxis hemerocallideafor herb–drug interaction

    Article • Pharmaceutical Biology, July 2013, Taylor & Francis

    Professor Bernd Rosenkranz

  8. Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area : cardiovascular topics

    Article • CardioVascular Journal of Africa, March 2013, Clinics Cardive Publishing

    Professor Bernd Rosenkranz

  9. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers

    Article • Epilepsia, January 2013, Wiley

    Professor Bernd Rosenkranz

  10. Liver-Based In Vitro Technologies for Drug Biotransformation Studies - A Review

    Article • Current Drug Metabolism, February 2012, Bentham Science Publishers

    Professor Bernd Rosenkranz

  11. An Overview of the Evidence and Mechanisms of Herb–Drug Interactions

    Article • Frontiers in Pharmacology, January 2012, Frontiers

    Professor Bernd Rosenkranz

  12. The Role of Therapeutic Drug Monitoring in the Management of Patients With Human Immunodeficiency Virus Infection

    Article • Therapeutic Drug Monitoring, June 2011, Wolters Kluwer Health

    Professor Bernd Rosenkranz

  13. Editorial [Hot Topic: Targeting Tuberculosis and HIV/AIDS: A Global Progress Report of a Deadly Partnership (Guest Editors: Jean B. Nachega & Bernd Rosenkranz)]

    Article • Infectious Disorders - Drug Targets, April 2011, Bentham Science Publishers

    Professor Bernd Rosenkranz

  14. Management of Adult Active Tuberculosis Disease in Era of HIV Pandemic, Current Practices and Future Perspectives

    Article • Infectious Disorders - Drug Targets, April 2011, Bentham Science Publishers

    Professor Bernd Rosenkranz

  15. Bioequivalence of dispersed stavudine: opened versus closed capsule dosing

    Article • Antiviral Therapy, January 2011, International Medical Press

    Professor Bernd Rosenkranz

  16. Blocking the bradykinin response: Pharmacodynamics and safety of icatibant, a potent and selective bradykinin B2 receptor antagonist

    Article • Molecular Immunology, October 2008, Elsevier

    Professor Bernd Rosenkranz

  17. Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study

    Article • Gastroenterology, September 2008, Elsevier

    Professor Bernd Rosenkranz

  18. Safety and tolerability of high-dose formoterol (via Aerolizer®) and salbutamol in patients with chronic obstructive pulmonary disease

    Article • Respiratory Medicine, April 2006, Elsevier

    Professor Bernd Rosenkranz

  19. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma

    Article • Pulmonary Pharmacology & Therapeutics, June 2005, Elsevier

    Professor Bernd Rosenkranz

  20. Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs

    Article • Clinical Pharmacokinetics, January 2005, Springer Science + Business Media

    Professor Bernd Rosenkranz

  21. Besonderheiten der Arzneitherapie im Alter unter Berücksichtigung pharmakogenetischer Faktoren

    Article • January 2004, Springer Science + Business Media

    Professor Bernd Rosenkranz

  22. Coordination and Conductance of Clinical Trials in Germany

    Article • International Journal of Pharmaceutical Medicine, January 2003, Springer Science + Business Media

    Professor Bernd Rosenkranz

  23. Pharmacokinetic and Pharmacodynamic Assessments of HMG‐CoA Reductase Inhibitors When Coadministered with Everolimus

    Article • The Journal of Clinical Pharmacology, February 2002, Wiley

    Professor Bernd Rosenkranz

  24. Propentofylline in the Treatment of Vascular Dementia and Alzheimer-Type Dementia

    Article • Alzheimer Disease & Associated Disorders, March 1998, Wolters Kluwer Health

    Professor Bernd Rosenkranz

  25. Clinical Pharmacokinetics of Molsidomine

    Article • Clinical Pharmacokinetics, May 1996, Springer Science + Business Media

    Professor Bernd Rosenkranz

  26. Clinical Pharmacokinetics of Dipyrone and its Metabolites

    Article • Clinical Pharmacokinetics, March 1995, Springer Science + Business Media

    Professor Bernd Rosenkranz

  27. Single-dose pharmacokinetics of cefpirome in patients with renal impairment

    Article • Clinical Pharmacology & Therapeutics, July 1992, Wiley

    Professor Bernd Rosenkranz

  28. Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs: in vitro and in vivo studies

    Article • European Journal of Pharmacology, January 1992, Elsevier

    Professor Bernd Rosenkranz

  29. Ofloxacin Pharmacokinetics in Chronic Renal Failure and Dialysis

    Article • Clinical Pharmacokinetics, November 1991, Springer Science + Business Media

    Professor Bernd Rosenkranz

  30. Glucocorticoid effect on arachidonic acid metabolism in vivo

    Article • Journal of Steroid Biochemistry, January 1988, Elsevier

    Professor Bernd Rosenkranz

  31. Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam

    Article • Clinical Pharmacology & Therapeutics, December 1985, Wiley

    Professor Bernd Rosenkranz

  32. Falsely Elevated Digoxin Concentrations in Patients with Liver Disease

    Article • Therapeutic Drug Monitoring, June 1985, Wolters Kluwer Health

    Professor Bernd Rosenkranz

  33. Effects of Sulfinpyrazone on Renal Function and Prostaglandin Formation in Man

    Article • January 1985, Karger Publishers

    Professor Bernd Rosenkranz

  34. Metabolic disposition of prostaglandin E1 in man

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, February 1983, Elsevier

    Professor Bernd Rosenkranz

  35. Investigations on Renal Prostaglandins by Gas Chromatography—Mass Spectrometry

    Article • January 1983, Springer Science + Business Media

    Professor Bernd Rosenkranz

  36. Relevance of urinary 6-keto-prostaglandin F1α determination

    Article • Kidney International, June 1981, Elsevier

    Professor Bernd Rosenkranz